Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses
Research and development	$ 66,116	$ 61,443	$ 161,842	$ 185,177
Selling, general and administrative	322,583	114,047	622,398	474,119
Total operating expenses	388,699	175,490	784,240	659,296
Gain on sale or transfer of assets and technology			(600,000)
Loss from operations	(388,699)	(175,490)	(184,240)	(659,296)
Other income (expenses):
Interest expense	(12,706)	(10,952)	(44,555)	(31,585)
Gain on accounts payable forgiveness		35,985	66,751	35,985
Total	(12,706)	25,033	22,196	4,400
Net loss	(401,405)	(150,457)	(162,044)	(654,896)
Net loss (income) attributable to the non-controlling interest	(40,273)	(19,790)	(86,935)	(71,490)
Net loss (income) attributable to the controlling interest	$ (361,132)	$ (130,667)	$ (75,109)	$ (583,406)
Net loss attributable to controlling interest per share:
Basic and diluted	$ (0.015)	$ (0.01)	$ (0.003)	$ (0.04)
Weighted average common shares outstanding	24,449,004	14,489,399	23,157,097	14,481,311